NCT05812157View on ClinicalTrials.gov

Optimizing Anti-IL17 Antibody Therapy by Associating Fiber Supplementation to Correct Treatment-aggravated Gut Dysbiosis in Axial Spondyloarthritis - RESPOND-IL17

NARecruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

October 2, 2023

Primary Completion Date

December 1, 2026

Study Completion Date

December 1, 2026

Conditions
Axial Spondyloarthritis
Interventions
DIETARY_SUPPLEMENT

Daily dietary supplementation with Fibruline

Supplementation with 12 grams per day of Fibruline reconstituted with 60mL of water, once a day

DRUG

Anti-IL-17 therapy

Patients in both groups will be on anti-IL-17 therapy

Trial Locations (3)

30029

RECRUITING

Nîmes University Hospital, Nîmes

34000

RECRUITING

Montpellier University Hospital, Montpellier

37032

RECRUITING

Tours Regional University Hospital (Bretonneau), Tours

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nīmes

OTHER